ESMO 2024
Fira Barcelona Gran Via Av. Joan Carles I, 64, Barcelona, SpainJoin Discovery Life Sciences at ESMO 2024 September 13-17, 2024 | Fira Barcelona Gran Via, Barcelona, Spain Visit Discovery at Booth #338 Schedule a Meeting at ESMO
A novel in vitro assay that incorporates hepatic metabolism into hematopoietic toxicity evaluation, addressing a critical gap that standard cytotoxicity assay platforms overlook.
By co-culturing Gentest® Cryopreserved Primary Hepatocytes with bone marrow-derived CD34+ cells exposed to xenobiotic compounds, we can accurately evaluate metabolism-dependent toxicity by measuring the clonogenic potential of CD34+ cells in a Colony Forming Cell (CFC) assay. Colony enumeration is executed by experienced cell biologists to ensure accurate and reliable results.
Incorporation of Hepatic Metabolism in the Hematopoietic Stem Cells (HSC) Toxicity Assay via Co-Culturing of HSC with Primary Human HepatocytesAbstracts & Posters
Join Discovery Life Sciences at ESMO 2024 September 13-17, 2024 | Fira Barcelona Gran Via, Barcelona, Spain Visit Discovery at Booth #338 Schedule a Meeting at ESMO
Join Discovery Life Sciences at ISSX North America 2024 September 15-18, 2024 | Hilton Hawaiian Village Waikiki Beach Resort, Honolulu, Hawaii Visit Discovery at Booth #113 You are also invited […]
Visit us at Booth #38 during the 9th CAR-TCR Summit Meeting, September 16-18 at Boston's Hynes Convention Center. You are also invited to our presentation on Day 1, Wednesday Sep […]
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing